Chun Dai

Title: Innovations in Tumor Monitoring by Chun Dai

Introduction

Chun Dai is an accomplished inventor based in Shanghai, China. She has made significant contributions to the field of medical technology, particularly in the monitoring of tumor evolution. Her innovative approach focuses on utilizing biomarker genes to assess tumor load in patients, which can lead to more personalized treatment options.

Latest Patents

Chun Dai holds a patent for "Systems and methods for monitoring lifelong tumor evolution." This patent describes a method for monitoring tumor load in a patient by selecting a predetermined number of biomarker genes from DNA extracted from a tumor tissue sample. The process involves isolating circulating cell-free DNA from a bodily fluid sample, enriching DNA sequences containing the biomarker genes, sequencing the enriched DNA, and counting the number of mutated and normal DNA sequencing reads. This method provides a comprehensive assessment of tumor load, which is crucial for effective treatment planning.

Career Highlights

Chun Dai has been instrumental in advancing the field of genomic medicine. Her work at Genomicare Biotechnology (Shanghai) Co. Ltd. has positioned her as a leader in the development of innovative solutions for cancer monitoring. With a focus on precision medicine, her contributions are paving the way for improved patient outcomes.

Collaborations

Chun Dai collaborates with notable colleagues, including Qiang Xu and Guan Zhong Wang. Their combined expertise enhances the research and development efforts at Genomicare Biotechnology, fostering an environment of innovation and discovery.

Conclusion

Chun Dai's work exemplifies the intersection of technology and healthcare, showcasing how innovative inventions can lead to significant advancements in patient care. Her contributions to tumor monitoring are vital in the ongoing fight against cancer, and her patent reflects a commitment to improving medical outcomes through scientific innovation.